B

Bicara Therapeutics Inc
NASDAQ:BCAX

Watchlist Manager
Bicara Therapeutics Inc
NASDAQ:BCAX
Watchlist
Price: 9.18 USD -1.5% Market Closed
Market Cap: 500.7m USD
Have any thoughts about
Bicara Therapeutics Inc?
Write Note

Wall Street
Price Targets

BCAX Price Targets Summary
Bicara Therapeutics Inc

Wall Street analysts forecast BCAX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BCAX is 33.25 USD with a low forecast of 8.08 USD and a high forecast of 50.4 USD.

Lowest
Price Target
8.08 USD
12% Downside
Average
Price Target
33.25 USD
262% Upside
Highest
Price Target
50.4 USD
449% Upside
Bicara Therapeutics Inc Competitors:
Price Targets
688373
Shanghai MicuRx Pharmaceutical Co Ltd
16% Downside
VYGR
Voyager Therapeutics Inc
455% Upside
CDNA
CareDx Inc
56% Upside
ABBV
Abbvie Inc
17% Upside
TRDA
Entrada Therapeutics Inc
197% Upside
MSB
Mesoblast Ltd
88% Upside
RXRX
Recursion Pharmaceuticals Inc
37% Upside
ONCO
Oncopeptides AB
299% Upside

Revenue
Forecast

Revenue Estimate
Bicara Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Bicara Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Bicara Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BCAX's stock price target?
Price Target
33.25 USD

According to Wall Street analysts, the average 1-year price target for BCAX is 33.25 USD with a low forecast of 8.08 USD and a high forecast of 50.4 USD.

Back to Top